May 24, 2021 7:30am EDT OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor
May 07, 2021 1:33pm EDT OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders
Apr 28, 2021 4:05pm EDT OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results
Apr 27, 2021 8:38am EDT Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year
Apr 01, 2021 8:28am EDT BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball
Feb 26, 2021 10:32am EST EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Feb 22, 2021 8:38am EST New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy
Feb 18, 2021 4:05pm EST OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results